A New Finite Element Approach for Near Real-Time Simulation of Light Propagation in Locally Advanced Head and Neck Tumors

被引:30
作者
Oakley, Emily [1 ]
Wrazen, Brian [1 ]
Bellnier, David A. [1 ,2 ]
Syed, Yusef [1 ]
Arshad, Hassan [1 ,2 ]
Shafirstein, Gal [1 ,2 ,3 ]
机构
[1] Roswell Pk Canc Inst, Photodynam Therapy Ctr, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Head & Neck Surg, Buffalo, NY 14263 USA
关键词
finite element; intersititial photodynamic therapy; head and neck cancer; INTERSTITIAL PHOTODYNAMIC THERAPY; COOPERATIVE-ONCOLOGY-GROUP; SQUAMOUS-CELL CARCINOMA; PULSED DYE-LASER; SELECTIVE PHOTOTHERMOLYSIS; PROSTATE-CANCER; RECURRENT HEAD; PLUS CETUXIMAB; REIRRADIATION; REFLECTANCE;
D O I
10.1002/lsm.22313
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and ObjectivesSeveral clinical studies suggest that interstitial photodynamic therapy (I-PDT) may benefit patients with locally advanced head and neck cancer (LAHNC). For I-PDT, the therapeutic light is delivered through optical fibers inserted into the target tumor. The complex anatomy of the head and neck requires careful planning of fiber insertions. Often the fibers' location and tumor optical properties may vary from the original plan therefore pretreatment planning needs near real-time updating to account for any changes. The purpose of this work was to develop a finite element analysis (FEA) approach for near real-time simulation of light propagation in LAHNC. MethodsOur previously developed FEA for modeling light propagation in skin tissue was modified to simulate light propagation from interstitial optical fibers. The modified model was validated by comparing the calculations with measurements in a phantom mimicking tumor optical properties. We investigated the impact of mesh element size and growth rate on the computation time, and defined optimal settings for the FEA. We demonstrated how the optimized FEA can be used for simulating light propagation in two cases of LAHNC amenable to I-PDT, as proof-of-concept. ResultsThe modified FEA was in agreement with the measurements (P=0.0271). The optimal maximum mesh size and growth rate were 0.005-0.02m and 2-2.5m/m, respectively. Using these settings the computation time for simulating light propagation in LAHNC was reduced from 25.9 to 3.7minutes in one case, and 10.1 to 4minutes in another case. There were minor differences (1.62%, 1.13%) between the radiant exposures calculated with either mesh in both cases. ConclusionsOur FEA approach can be used to model light propagation from diffused optical fibers in complex heterogeneous geometries representing LAHNC. There is a range of maximum element size (MES) and maximum element growth rate (MEGR) that can be used to minimize the computation time of the FEA to 4minutes. Lasers Surg. Med. 47:60-67, 2015. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 29 条
  • [1] In vivo photosensitizer tomography inside the human prostate
    Axelsson, Johan
    Swartling, Johannes
    Andersson-Engels, Stefan
    [J]. OPTICS LETTERS, 2009, 34 (03) : 232 - 234
  • [2] Selective photothermolysis of blood vessels following flashlamp-pumped pulsed dye laser irradiation:: In vivo results and mathematical modelling are in agreement
    Babilas, P
    Shafirstein, G
    Bäumler, W
    Baier, J
    Landthaler, M
    Szeimies, RM
    Abels, C
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (02) : 343 - 352
  • [3] Photothermolysis of blood vessels using indocyanine green and pulsed diode laser irradiation in the dorsal skinfold chamber model
    Babilas, Philipp
    Shafirstein, Gal
    Baier, Juergen
    Schacht, Vivien
    Szeimies, Rolf-Markus
    Landthaler, Michael
    Baeumler, Wolfgang
    Abels, Christoph
    [J]. LASERS IN SURGERY AND MEDICINE, 2007, 39 (04) : 341 - 352
  • [4] Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm
    Baeumler, W.
    Ulrich, H.
    Hartl, A.
    Landthaler, M.
    Shafirstein, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (02) : 364 - 371
  • [5] The effects of intense pulsed light (IPL) on blood vessels investigated by mathematical modeling
    Baeumler, Wolfgang
    Vural, Emre
    Landthaler, Michael
    Muzzi, Francesco
    Shafirstein, Gal
    [J]. LASERS IN SURGERY AND MEDICINE, 2007, 39 (02) : 132 - 139
  • [6] Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
    Burtness, B
    Goldwasser, MA
    Flood, W
    Mattar, B
    Forastiere, AA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8646 - 8654
  • [7] PRACTICAL CONSIDERATIONS IN THE RE-IRRADIATION OF RECURRENT AND SECOND PRIMARY HEAD-AND-NECK CANCER: WHO, WHY, HOW, AND HOW MUCH?
    Chen, Allen M.
    Phillips, Theodore L.
    Lee, Nancy Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1211 - 1219
  • [8] Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer
    Davidson, Sean R. H.
    Weersink, Robert A.
    Haider, Masoom A.
    Gertner, Mark R.
    Bogaards, Arjen
    Giewercer, David
    Scherz, Avigdor
    Sherar, Michael D.
    Elhilali, Mostafa
    Chin, Joseph L.
    Trachtenberg, John
    Wilson, Brian C.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2009, 54 (08) : 2293 - 2313
  • [9] Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer
    Du, K. L.
    Mick, R.
    Busch, T. M.
    Zhu, T. C.
    Finlay, J. C.
    Yu, G.
    Yodh, A. G.
    Malkowicz, S. B.
    Smith, D.
    Whittington, R.
    Stripp, D.
    Hahn, S. M.
    [J]. LASERS IN SURGERY AND MEDICINE, 2006, 38 (05) : 427 - 434
  • [10] Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group
    Gibson, MK
    Li, Y
    Murphy, B
    Hussain, MHA
    DeConti, RC
    Ensley, J
    Forastiere, AA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3562 - 3567